Display options
Cite
Vallat JM, Tabaraud F, Magy L, et al. Polyradiculonévrites chroniques et leurs frontières. [Chronic inflammatory demyelinating neuropathies and their variants]. Rev Neurol (Paris). 2002;158(123):27-31
Vallat, J. M., Tabaraud, F., Magy, L., & Macian, F. (2002). Polyradiculonévrites chroniques et leurs frontières. [Chronic inflammatory demyelinating neuropathies and their variants]. Revue neurologique, 158(123), 27-31.
Vallat, J.-M., et al. "Polyradiculonévrites chroniques et leurs frontières." [Chronic inflammatory demyelinating neuropathies and their variants]. Revue neurologique vol. 158,123 (2002): 27-31.
Vallat JM, Tabaraud F, Magy L, Macian F. Polyradiculonévrites chroniques et leurs frontières. [Chronic inflammatory demyelinating neuropathies and their variants]. Rev Neurol (Paris). 2002 Dec;158(123):27-31. French. PMID: 12690330.
Copy Download .nbib Format: NLM
Share it on

Rev Neurol (Paris). 2002 Dec;158(123):27-31.

[Chronic inflammatory demyelinating neuropathies and their variants].

Revue neurologique

[Article in French]
J.-M. Vallat, F. Tabaraud, L. Magy, F. Macian

PMID: 12690330

Abstract

The Chronic Inflammatory Demyelinating Polyradiculoneuropathies (CIDP) constitute a syndrome whose incidence is difficult to evaluate, and is probably underestimated. In the course of this presentation, we deliberately restricted discussion to issues raised in recent years concerning the extent of this syndrome. We discuss diagnostic criteria, especially electrophysiological ones. As the criteria proposed by the ad hoc committee of the American Academy of Neurology in 1991 have been questioned due to lack of sensitivity, new ones have been proposed recently. We briefly discuss the different types of chronic dysimmune demyelinating neuropathy: not only the CIDP, but also the Lewis and Sumner syndrome or multifocal inflammatory demyelinating neuropathy and the multiple conduction block neuropathies. At last, we point out the consistent finding of axonal involvement in the course of a chronic demyelinating neuropathy; over time, it can become predominant, which may make diagnosis difficult by suggesting a chronic axonal neuropathy that may be assumed to be primary. Consideration of these points may help clinicians recognize more chronic dysimmune neuropathies, for which immunosuppressive therapy has been found to be effective.

Publication Types